Andrew T. Lucas

649 total citations
30 papers, 523 citations indexed

About

Andrew T. Lucas is a scholar working on Biomaterials, Oncology and Molecular Biology. According to data from OpenAlex, Andrew T. Lucas has authored 30 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomaterials, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Andrew T. Lucas's work include Nanoparticle-Based Drug Delivery (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Andrew T. Lucas is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Andrew T. Lucas collaborates with scholars based in United States, Israel and Belgium. Andrew T. Lucas's co-authors include William C. Zamboni, Allison N. Schorzman, Joseph Piscitelli, Lauren Price, Carla V. Finkielstein, Daniel G. S. Capelluto, Jianhua Yang, Charlene Santos, János Szebeni and Marina A. Dobrovolskaia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Andrew T. Lucas

28 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew T. Lucas United States 13 218 146 119 100 92 30 523
Maja Thim Larsen Denmark 6 356 1.6× 108 0.7× 176 1.5× 130 1.3× 104 1.1× 6 655
Mauro Sergi Italy 7 289 1.3× 69 0.5× 111 0.9× 59 0.6× 73 0.8× 9 530
J.S. Josan United States 14 314 1.4× 95 0.7× 64 0.5× 136 1.4× 63 0.7× 19 546
Rossella Di Stasi Italy 16 377 1.7× 89 0.6× 97 0.8× 88 0.9× 60 0.7× 33 595
Peter Qiao United States 14 148 0.7× 73 0.5× 100 0.8× 57 0.6× 125 1.4× 20 525
Patrick J. Kennedy Portugal 15 361 1.7× 94 0.6× 147 1.2× 161 1.6× 125 1.4× 21 706
Izumi O. Umeda Japan 15 223 1.0× 90 0.6× 129 1.1× 176 1.8× 124 1.3× 52 620
Na Qu China 14 365 1.7× 92 0.6× 141 1.2× 39 0.4× 94 1.0× 56 754
Freddy Schoetens United States 6 287 1.3× 69 0.5× 140 1.2× 84 0.8× 88 1.0× 6 705
Li-Peng Yap United States 10 229 1.1× 101 0.7× 56 0.5× 124 1.2× 105 1.1× 16 460

Countries citing papers authored by Andrew T. Lucas

Since Specialization
Citations

This map shows the geographic impact of Andrew T. Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew T. Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew T. Lucas more than expected).

Fields of papers citing papers by Andrew T. Lucas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew T. Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew T. Lucas. The network helps show where Andrew T. Lucas may publish in the future.

Co-authorship network of co-authors of Andrew T. Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew T. Lucas. A scholar is included among the top collaborators of Andrew T. Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew T. Lucas. Andrew T. Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Li, Andrew T. Lucas, Aaron S. Mansfield, et al.. (2025). Evaluation of Innate Immune System, Body Habitus, and Sex on the Pharmacokinetics and Pharmacodynamics of Anetumab Ravtansine in Patients With Cancer. Clinical and Translational Science. 18(3). e70178–e70178. 3 indexed citations
2.
Wang, Zhangjie, et al.. (2022). Investigation of the pharmacokinetic properties of synthetic heparan sulfate oligosaccharides. Glycobiology. 33(2). 104–114. 4 indexed citations
3.
Ilich, Anton, Terry Gernsheimer, Darrell J. Triulzi, et al.. (2022). Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia. Blood Advances. 7(6). 900–908. 3 indexed citations
4.
Ilich, Anton, Terry Gernsheimer, Darrell J. Triulzi, et al.. (2021). Absence of Hyperactivation of Fibrinolysis Explains the Lack of Hemostatic Efficacy of Prophylactic Tranexamic Acid (TXA) in Hypoproliferative Thrombocytopenia. Blood. 138(Supplement 1). 2094–2094.
5.
6.
Parker, Christina L., Morgan D. McSweeney, Andrew T. Lucas, et al.. (2019). Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2. Nanomedicine Nanotechnology Biology and Medicine. 21. 102076–102076. 21 indexed citations
7.
8.
Kumar, Parag, Andrew T. Lucas, David A. Barrow, et al.. (2018). Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients. Cancer Chemotherapy and Pharmacology. 83(1). 61–70. 11 indexed citations
9.
Schorzman, Allison N., et al.. (2018). Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents. Methods in molecular biology. 1831. 201–228. 9 indexed citations
10.
Zamboni, William C., János Szebeni, Serguei Kozlov, et al.. (2018). Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations. Advanced Drug Delivery Reviews. 136-137. 82–96. 46 indexed citations
11.
Lucas, Andrew T., Alberto Gabizón, Alexander V. Kabanov, et al.. (2017). Pharmacokinetic and screening studies of the interaction between mononuclear phagocyte system and nanoparticle formulations and colloid forming drugs. International Journal of Pharmaceutics. 526(1-2). 443–454. 16 indexed citations
12.
Lucas, Andrew T., Lauren Price, Allison N. Schorzman, & William C. Zamboni. (2017). Complex Effects of Tumor Microenvironment on the Tumor Disposition of carrier-mediated Agents. Nanomedicine. 12(16). 2021–2042. 12 indexed citations
13.
Song, Gina, Oscar Suzuki, Charlene Santos, et al.. (2016). Gulp1 is associated with the pharmacokinetics of PEGylated liposomal doxorubicin (PLD) in inbred mouse strains. Nanomedicine Nanotechnology Biology and Medicine. 12(7). 2007–2017. 10 indexed citations
14.
Lucas, Andrew T., et al.. (2016). Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models. Nanomedicine Nanotechnology Biology and Medicine. 13(2). 471–482. 14 indexed citations
15.
Lucas, Andrew T., et al.. (2016). Determining the Need for Standardized Infusions and Concentrations at Hospitals within North Carolina. Hospital Pharmacy. 51(3). 237–245. 3 indexed citations
16.
Lucas, Andrew T., et al.. (2015). Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents. Expert Opinion on Drug Metabolism & Toxicology. 11(9). 1419–1433. 15 indexed citations
17.
Lucas, Andrew T., et al.. (2015). A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissues. Journal of Pharmaceutical and Biomedical Analysis. 119. 122–129. 36 indexed citations
18.
Capelluto, Daniel G. S., Xiaolin Zhao, Andrew T. Lucas, et al.. (2014). Biophysical and Molecular-Dynamics Studies of Phosphatidic Acid Binding by the Dvl-2 DEP Domain. Biophysical Journal. 106(5). 1101–1111. 20 indexed citations
19.
Lucas, Andrew T., et al.. (2014). Ligand Binding Reveals a Role for Heme in Translationally-Controlled Tumor Protein Dimerization. PLoS ONE. 9(11). e112823–e112823. 8 indexed citations
20.
Martinez, Marilyn N., Bernadette Dunham, Robert P. Hunter, et al.. (2005). American Academy of Veterinary Pharmacology and Therapeutics 14th Biennial Symposium. Journal of Veterinary Pharmacology and Therapeutics. 28(5). 495–498. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maja Thim Larsen Breakdown of academic impact, for papers by Mauro Sergi Breakdown of academic impact, for papers by J.S. Josan Breakdown of academic impact, for papers by Rossella Di Stasi Breakdown of academic impact, for papers by Peter Qiao Breakdown of academic impact, for papers by Patrick J. Kennedy Breakdown of academic impact, for papers by Izumi O. Umeda Breakdown of academic impact, for papers by Na Qu Breakdown of academic impact, for papers by Freddy Schoetens Breakdown of academic impact, for papers by Li-Peng Yap
Rankless by CCL
2026